Interventional cardiology in a whole new light

Open menu

News & Events

$1.2 M ORDERS FOR OPSENS’ FFR PRODUCTS

30 November 2015

OPSENS RECEIVES ORDERS WORTH $1.2 MILLION FOR ITS FFR PRODUCTS FROM JAPAN Quebec City, Quebec, November 30, 2015 – Opsens Inc. (“Opsens” or the “Company”) (TSXV:OPS) (OTCQX:OPSSF) is pleased to announce receipt of orders worth over $1.2 million for its products to measure Fractional Flow Reserve (“FFR”) from the Japanese market. Opsens’ FFR products are…

Read more

OPSENS GRANTED APPROVAL TO SELL OPTOWIRE II IN JAPAN

26 November 2015

OPSENS granted approval to sell Optowire II in Japan Quebec City, Quebec, November 26, 2015 – Opsens Inc. (“Opsens” or the “Company”) (TSXV:OPS) (OTCQX:OPSSF) is pleased to announce that its Japanese partner has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (“MHLW”) to sell the OptoWire II. OptoWire II for Improved…

Read more

OPSENS REPORTS 2015 RESULTS

24 November 2015

Opsens reports 2015 results Quebec City, Quebec, November 24, 2015 – Opsens Inc. (“Opsens”) (TSXV:OPS) (OTCQX:OPSSF) today released results for the year ended August 31, 2015. Highlights Revenues rise 28% to $8.7 million in fiscal 2015 from $6.8 million a year earlier; Net loss at $2.9 million in fiscal 2015 reduced from $3.1 million a…

Read more

OPSENS APPROVED TO SELL OPTOWIRE II IN EUROPE

12 November 2015

OPSENS GRANTED APPROVAL TO SELL OPTOWIRE II IN EUROPE Quebec City, Quebec, November 12, 2015 – Opsens Inc. (“Opsens” or the “Company”) (TSXV:OPS) (OTCQX:OPSSF) is pleased to announce it has been granted CE marking for the OptoWire II, the improved version of its pressure guidewire (OptoWire I) developed to measure Fractional Flow Reserve (“FFR”) in patients…

Read more

Opsens – First use of its FFR products in the U.S.

12 November 2015

OPSENS ANNOUNCES FIRST USE OF ITS FFR PRODUCTS IN THE UNITED STATES Quebec City, Quebec, November 11, 2015 – Opsens Inc. (“Opsens” or the “Company”) (TSXV:OPS) (OTCQX:OPSSF) is pleased to announce that the OptoWire and OptoMonitor, its products to measure Fractional Flow Reserve (“FFR”), were used for the first time in the United States by…

Read more

Opsens – 1,000th procedure with the OptoWire

12 November 2015

OPSENS performs 1,000th procedure with the Optowire Quebec, Quebec, October 28, 2015 – Opsens Inc. (“Opsens” or the “Company”) (TSXV:OPS) (OTCQX:OPSSF) is pleased to announce that the OptoWire, its guidewire to measure Fractional Flow Reserve (“FFR”), which is designed to optimize and guide treatment in patients with coronary heart disease, has been used as a diagnostic…

Read more